Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients.
about
Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.P selectins and immunological profiles in HCV and Schistosoma mansoni induced chronic liver diseasePersistent immune activation in chronic HIV infection: do any interventions work?The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfectionIncreased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C--a cross-sectional study.Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.HIV as a Cause of Immune Activation and Immunosenescence.A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease.Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based studyExamining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q33803319-47F9DF05-AC2B-4623-8935-AF00C0385AEDQ33990741-851ADC07-C894-4FF7-BBDD-4B26803133D1Q34851102-31FA6C31-0E5E-4B71-92FB-CA862623BF97Q35072020-0D46AFE9-E7DD-43ED-9301-B82207870DA1Q37525930-CC35E6DF-03DB-4E91-B197-89432AB51599Q38153794-95279398-CFF0-4086-BA7C-D607C098C98AQ39008634-FF78B5DE-7A7B-40C9-9039-9765AD12305BQ47151081-7543EAE9-9530-478F-B2ED-A47BC2B3366DQ47405719-798C0A89-016F-46E7-8BB1-10E22BD8A854Q57276037-AE867145-4798-43D3-AF13-40608CF7798EQ58549748-6C9C750F-63FE-4E58-99B3-A5F1E606E2F3
P2860
Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Sustained virological response ...... HIV/HCV co-infected patients.
@en
Sustained virological response ...... HIV/HCV co-infected patients.
@nl
type
label
Sustained virological response ...... HIV/HCV co-infected patients.
@en
Sustained virological response ...... HIV/HCV co-infected patients.
@nl
prefLabel
Sustained virological response ...... HIV/HCV co-infected patients.
@en
Sustained virological response ...... HIV/HCV co-infected patients.
@nl
P2093
P2860
P50
P356
P1476
Sustained virological response ...... HIV/HCV co-infected patients.
@en
P2093
Dariela Micheloud
Jaime Cosín
Juan Berenguer
Juan Carlos López
María Guzmán-Fulgencio
Pilar Miralles
Teresa Aldamiz-Echevarría
P2860
P304
P356
10.1093/JAC/DKQ518
P407
P577
2011-01-14T00:00:00Z